NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|351058118|emb|CCD64735|]
View 

NEPrilysin metallopeptidase family [Caenorhabditis elegans]

Protein Classification

M13 family metallopeptidase( domain architecture ID 10171382)

M13 family metallopeptidase similar to neutral endopeptidase (neprilysin), which degrades and inactivates bioactive peptides, and to endothelin-converting enzyme, which catalyzes the hydrolysis of the bond between Trp-21 and Val-22 in big endothelin to form endothelin 1

EC:  3.4.24.-
MEROPS:  M13
SCOP:  3001975

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
97-709 2.74e-126

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


:

Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 389.42  E-value: 2.74e-126
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118  97 VDPCQDFYQHFCGKFYEHSAIGQGRMATKR-STLSKLIREFLLK------NKTSTSKSENTMKQVYAKCRELQKISDLNS 169
Cdd:cd08662    1 VDPCDDFYQYACGNWLKNHPIPADKSSWGSfSELQDRNEEQLREileeaaSSAADSSAEQKAKDFYKSCMDEEAIEKLGL 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 170 IPpqalldIFSDIKKIGAWPVLDKDWDGSKFNLNEML------------------RQLVNLGETHLGFFHFDFIARPyvl 231
Cdd:cd08662   81 KP------LKPLLDKIGGLPSLDDLAAELLLALLRRLgvsllfglgvspdpknssRNILYLGQPGLGLPDRDYYLDE--- 151
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 232 ikpplKQGVQKSVLEKVVKMILEANEIKMDQgFSEDLDEYFELSNRIKIDKLPRTSR----------SIVGLLPDVRRIN 301
Cdd:cd08662  152 -----ENAEIREAYKKYIAKLLELLGADEEE-AEKLAEDVLAFETELAKISLSSEELrdpektynplTLAELQKLAPSID 225
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 302 FRGLILEMMPRSKMNrflgtlfqKVVTYHHPLFVRdnetnHLDTIIRSTSNRALANYLIFNFIHSSIKFL---------- 371
Cdd:cd08662  226 WKAYLKALGPPADDP--------DKVIVSQPEYLK-----KLDKLLASTPLRTLKNYLIWRLLDSLAPYLskefrdarff 292
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 372 -------TFGLKSDRERCEKIVVQELPRPSLRVFMRNCVDKGNREEVAKLTETVKENVLEMIRESDSFTPSVKKRVLKKV 444
Cdd:cd08662  293 ygkalsgQKEPEPRWKRCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLDWMDEETKKKALEKL 372
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 445 EAIGAIIGYPDHFDPPGTLDKEYENLTLdaSDSYYKMSQKLHQLRLQHQMEFLAGQT-----PLSPSdqvlEVNAHYDSK 519
Cdd:cd08662  373 DAMKVKIGYPDKWRDYSALDIYYDDLNV--SDSYFENVLRLLRFETKRQLAKLGKPVdrtewSMSPQ----TVNAYYNPS 446
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 520 DNALTVLAPFLDDPFFDSTYPEYVNLIFTGFLIGHEFGHSIDPKILRRDG------WYKTEDMTEYGKRAQCLIDQYDNY 593
Cdd:cd08662  447 LNEIVFPAGILQPPFFDPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDEngnlrnWWTNEDRKEFEERAQCLVDQYSNY 526
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 594 DDPDhGKQMNGTYCIGEIVGDWVGRDVTWRAFKKMDLSKMQKLIGFEDKNLDQLYFRIQSLFFCGPRSMKSLE-QLLSDP 672
Cdd:cd08662  527 EVPP-GLHVNGKLTLGENIADNGGLRLAYRAYKKWLKENGPELPGLEGFTPEQLFFLSFAQVWCSKYRPEALRqLLLTDP 605
                        650       660       670
                 ....*....|....*....|....*....|....*..
gi 351058118 673 HPTEVFRVNGIYSNMPQFAKAFNCPIGSPMNPEKKCK 709
Cdd:cd08662  606 HSPGKFRVNGPLSNSPEFAEAFNCPPGSPMNPEKKCR 642
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
97-709 2.74e-126

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 389.42  E-value: 2.74e-126
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118  97 VDPCQDFYQHFCGKFYEHSAIGQGRMATKR-STLSKLIREFLLK------NKTSTSKSENTMKQVYAKCRELQKISDLNS 169
Cdd:cd08662    1 VDPCDDFYQYACGNWLKNHPIPADKSSWGSfSELQDRNEEQLREileeaaSSAADSSAEQKAKDFYKSCMDEEAIEKLGL 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 170 IPpqalldIFSDIKKIGAWPVLDKDWDGSKFNLNEML------------------RQLVNLGETHLGFFHFDFIARPyvl 231
Cdd:cd08662   81 KP------LKPLLDKIGGLPSLDDLAAELLLALLRRLgvsllfglgvspdpknssRNILYLGQPGLGLPDRDYYLDE--- 151
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 232 ikpplKQGVQKSVLEKVVKMILEANEIKMDQgFSEDLDEYFELSNRIKIDKLPRTSR----------SIVGLLPDVRRIN 301
Cdd:cd08662  152 -----ENAEIREAYKKYIAKLLELLGADEEE-AEKLAEDVLAFETELAKISLSSEELrdpektynplTLAELQKLAPSID 225
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 302 FRGLILEMMPRSKMNrflgtlfqKVVTYHHPLFVRdnetnHLDTIIRSTSNRALANYLIFNFIHSSIKFL---------- 371
Cdd:cd08662  226 WKAYLKALGPPADDP--------DKVIVSQPEYLK-----KLDKLLASTPLRTLKNYLIWRLLDSLAPYLskefrdarff 292
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 372 -------TFGLKSDRERCEKIVVQELPRPSLRVFMRNCVDKGNREEVAKLTETVKENVLEMIRESDSFTPSVKKRVLKKV 444
Cdd:cd08662  293 ygkalsgQKEPEPRWKRCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLDWMDEETKKKALEKL 372
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 445 EAIGAIIGYPDHFDPPGTLDKEYENLTLdaSDSYYKMSQKLHQLRLQHQMEFLAGQT-----PLSPSdqvlEVNAHYDSK 519
Cdd:cd08662  373 DAMKVKIGYPDKWRDYSALDIYYDDLNV--SDSYFENVLRLLRFETKRQLAKLGKPVdrtewSMSPQ----TVNAYYNPS 446
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 520 DNALTVLAPFLDDPFFDSTYPEYVNLIFTGFLIGHEFGHSIDPKILRRDG------WYKTEDMTEYGKRAQCLIDQYDNY 593
Cdd:cd08662  447 LNEIVFPAGILQPPFFDPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDEngnlrnWWTNEDRKEFEERAQCLVDQYSNY 526
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 594 DDPDhGKQMNGTYCIGEIVGDWVGRDVTWRAFKKMDLSKMQKLIGFEDKNLDQLYFRIQSLFFCGPRSMKSLE-QLLSDP 672
Cdd:cd08662  527 EVPP-GLHVNGKLTLGENIADNGGLRLAYRAYKKWLKENGPELPGLEGFTPEQLFFLSFAQVWCSKYRPEALRqLLLTDP 605
                        650       660       670
                 ....*....|....*....|....*....|....*..
gi 351058118 673 HPTEVFRVNGIYSNMPQFAKAFNCPIGSPMNPEKKCK 709
Cdd:cd08662  606 HSPGKFRVNGPLSNSPEFAEAFNCPPGSPMNPEKKCR 642
Peptidase_M13 pfam01431
Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which ...
513-708 3.63e-69

Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which are known, or believed to activate or inactivate oligopeptide (pro)-hormones such as opioid peptides. The family also contains a bacterial member believed to be involved with milk protein cleavage.


Pssm-ID: 279739 [Multi-domain]  Cd Length: 205  Bit Score: 224.99  E-value: 3.63e-69
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118  513 NAHYDSKDNALTVLAPFLDDPFFDSTYPEYVNLIFTGFLIGHEFGHSIDPKILRRD------GWYKTEDMTEYGKRAQCL 586
Cdd:pfam01431   1 NAYYQPNRNEIVFPAAILQPPFFDPNYPRAVNYGGIGNVIAHEITHGFDDQGAQFDkdgnlrSWWTDEDAEEFKDRAQCL 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118  587 IDQYDNYDDPDHGKQMNGTYCIGEIVGDWVGRDVTWRAFKKMDLSKMQKLIGFEDKNLDQLYFRIQSLFFCGPRSM-KSL 665
Cdd:pfam01431  81 IEQYSEYTPPDGTKCANGTLTLGENIADLGGLTIALRAYKKLLSANETVLPGFENLTPDQLFFRGAAQIWCMKQSPaEVL 160
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|...
gi 351058118  666 EQLLSDPHPTEVFRVNGIYSNMPQFAKAFNCPIGSPMNPEKKC 708
Cdd:pfam01431 161 RQLLVDPHSPPEFRVNGVMSNMPAFYEAFNCPEGDKMNPEPRC 203
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
342-709 2.94e-36

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 145.30  E-value: 2.94e-36
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 342 HLDTIIRSTSNRALANYLIFNFIHSSIKFLT-------F--------GLKSDRERcEKIVVQElprpslrvfmrncVDKG 406
Cdd:COG3590  288 ALDKLLASTPLEDWKAYLRWHLLDSAAPYLSkafvdanFdfygktlsGQKEQRPR-WKRAVAL-------------VNGA 353
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 407 NREEVAKL------TETVKENVLEM-----------IRESDSFTPSVKKRVLKKVEAIGAIIGYPDHFdppgtldKEYEN 469
Cdd:COG3590  354 LGEALGQLyveryfPPEAKARMEELvanlraayrerIENLDWMSPETKAKALEKLAAFTPKIGYPDKW-------RDYSG 426
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 470 LTLDAsDSYYKMSQKLHQLRLQHQMEFLaGQtplsPSD--------QvlEVNAHYDSKDNALTVLAPFLDDPFFDSTYPE 541
Cdd:COG3590  427 LEIKR-DDLVGNVLRASAFEYQRELAKL-GK----PVDrtewgmtpQ--TVNAYYNPTMNEIVFPAAILQPPFFDPKADD 498
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 542 YVNLIFTGFLIGHEFGHSIDPKILRRDG------WYKTEDMTEYGKRAQCLIDQYDNYDdPDHGKQMNGTYCIGEIVGDW 615
Cdd:COG3590  499 AVNYGGIGAVIGHEITHGFDDQGSQFDGdgnlrnWWTPEDRAAFEARTKKLVAQYDAYE-PLPGLHVNGKLTLGENIADL 577
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 616 VGRDVTWRAFKKMDLSKMQKLI-GFEDknlDQLYF-----------RIQSLffcgprsmksLEQLLSDPHPTEVFRVNGI 683
Cdd:COG3590  578 GGLSIAYDAYKLSLKGKEAPVIdGFTG---DQRFFlgwaqvwrskaRDEAL----------RQRLATDPHSPGEFRVNGP 644
                        410       420
                 ....*....|....*....|....*...
gi 351058118 684 YSNMPQFAKAFNCPIGSPM--NPEKKCK 709
Cdd:COG3590  645 VRNLDAFYEAFDVKPGDKMylAPEDRVR 672
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
97-709 2.74e-126

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 389.42  E-value: 2.74e-126
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118  97 VDPCQDFYQHFCGKFYEHSAIGQGRMATKR-STLSKLIREFLLK------NKTSTSKSENTMKQVYAKCRELQKISDLNS 169
Cdd:cd08662    1 VDPCDDFYQYACGNWLKNHPIPADKSSWGSfSELQDRNEEQLREileeaaSSAADSSAEQKAKDFYKSCMDEEAIEKLGL 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 170 IPpqalldIFSDIKKIGAWPVLDKDWDGSKFNLNEML------------------RQLVNLGETHLGFFHFDFIARPyvl 231
Cdd:cd08662   81 KP------LKPLLDKIGGLPSLDDLAAELLLALLRRLgvsllfglgvspdpknssRNILYLGQPGLGLPDRDYYLDE--- 151
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 232 ikpplKQGVQKSVLEKVVKMILEANEIKMDQgFSEDLDEYFELSNRIKIDKLPRTSR----------SIVGLLPDVRRIN 301
Cdd:cd08662  152 -----ENAEIREAYKKYIAKLLELLGADEEE-AEKLAEDVLAFETELAKISLSSEELrdpektynplTLAELQKLAPSID 225
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 302 FRGLILEMMPRSKMNrflgtlfqKVVTYHHPLFVRdnetnHLDTIIRSTSNRALANYLIFNFIHSSIKFL---------- 371
Cdd:cd08662  226 WKAYLKALGPPADDP--------DKVIVSQPEYLK-----KLDKLLASTPLRTLKNYLIWRLLDSLAPYLskefrdarff 292
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 372 -------TFGLKSDRERCEKIVVQELPRPSLRVFMRNCVDKGNREEVAKLTETVKENVLEMIRESDSFTPSVKKRVLKKV 444
Cdd:cd08662  293 ygkalsgQKEPEPRWKRCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLDWMDEETKKKALEKL 372
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 445 EAIGAIIGYPDHFDPPGTLDKEYENLTLdaSDSYYKMSQKLHQLRLQHQMEFLAGQT-----PLSPSdqvlEVNAHYDSK 519
Cdd:cd08662  373 DAMKVKIGYPDKWRDYSALDIYYDDLNV--SDSYFENVLRLLRFETKRQLAKLGKPVdrtewSMSPQ----TVNAYYNPS 446
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 520 DNALTVLAPFLDDPFFDSTYPEYVNLIFTGFLIGHEFGHSIDPKILRRDG------WYKTEDMTEYGKRAQCLIDQYDNY 593
Cdd:cd08662  447 LNEIVFPAGILQPPFFDPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDEngnlrnWWTNEDRKEFEERAQCLVDQYSNY 526
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 594 DDPDhGKQMNGTYCIGEIVGDWVGRDVTWRAFKKMDLSKMQKLIGFEDKNLDQLYFRIQSLFFCGPRSMKSLE-QLLSDP 672
Cdd:cd08662  527 EVPP-GLHVNGKLTLGENIADNGGLRLAYRAYKKWLKENGPELPGLEGFTPEQLFFLSFAQVWCSKYRPEALRqLLLTDP 605
                        650       660       670
                 ....*....|....*....|....*....|....*..
gi 351058118 673 HPTEVFRVNGIYSNMPQFAKAFNCPIGSPMNPEKKCK 709
Cdd:cd08662  606 HSPGKFRVNGPLSNSPEFAEAFNCPPGSPMNPEKKCR 642
Peptidase_M13 pfam01431
Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which ...
513-708 3.63e-69

Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which are known, or believed to activate or inactivate oligopeptide (pro)-hormones such as opioid peptides. The family also contains a bacterial member believed to be involved with milk protein cleavage.


Pssm-ID: 279739 [Multi-domain]  Cd Length: 205  Bit Score: 224.99  E-value: 3.63e-69
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118  513 NAHYDSKDNALTVLAPFLDDPFFDSTYPEYVNLIFTGFLIGHEFGHSIDPKILRRD------GWYKTEDMTEYGKRAQCL 586
Cdd:pfam01431   1 NAYYQPNRNEIVFPAAILQPPFFDPNYPRAVNYGGIGNVIAHEITHGFDDQGAQFDkdgnlrSWWTDEDAEEFKDRAQCL 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118  587 IDQYDNYDDPDHGKQMNGTYCIGEIVGDWVGRDVTWRAFKKMDLSKMQKLIGFEDKNLDQLYFRIQSLFFCGPRSM-KSL 665
Cdd:pfam01431  81 IEQYSEYTPPDGTKCANGTLTLGENIADLGGLTIALRAYKKLLSANETVLPGFENLTPDQLFFRGAAQIWCMKQSPaEVL 160
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|...
gi 351058118  666 EQLLSDPHPTEVFRVNGIYSNMPQFAKAFNCPIGSPMNPEKKC 708
Cdd:pfam01431 161 RQLLVDPHSPPEFRVNGVMSNMPAFYEAFNCPEGDKMNPEPRC 203
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
342-709 2.94e-36

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 145.30  E-value: 2.94e-36
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 342 HLDTIIRSTSNRALANYLIFNFIHSSIKFLT-------F--------GLKSDRERcEKIVVQElprpslrvfmrncVDKG 406
Cdd:COG3590  288 ALDKLLASTPLEDWKAYLRWHLLDSAAPYLSkafvdanFdfygktlsGQKEQRPR-WKRAVAL-------------VNGA 353
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 407 NREEVAKL------TETVKENVLEM-----------IRESDSFTPSVKKRVLKKVEAIGAIIGYPDHFdppgtldKEYEN 469
Cdd:COG3590  354 LGEALGQLyveryfPPEAKARMEELvanlraayrerIENLDWMSPETKAKALEKLAAFTPKIGYPDKW-------RDYSG 426
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 470 LTLDAsDSYYKMSQKLHQLRLQHQMEFLaGQtplsPSD--------QvlEVNAHYDSKDNALTVLAPFLDDPFFDSTYPE 541
Cdd:COG3590  427 LEIKR-DDLVGNVLRASAFEYQRELAKL-GK----PVDrtewgmtpQ--TVNAYYNPTMNEIVFPAAILQPPFFDPKADD 498
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 542 YVNLIFTGFLIGHEFGHSIDPKILRRDG------WYKTEDMTEYGKRAQCLIDQYDNYDdPDHGKQMNGTYCIGEIVGDW 615
Cdd:COG3590  499 AVNYGGIGAVIGHEITHGFDDQGSQFDGdgnlrnWWTPEDRAAFEARTKKLVAQYDAYE-PLPGLHVNGKLTLGENIADL 577
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118 616 VGRDVTWRAFKKMDLSKMQKLI-GFEDknlDQLYF-----------RIQSLffcgprsmksLEQLLSDPHPTEVFRVNGI 683
Cdd:COG3590  578 GGLSIAYDAYKLSLKGKEAPVIdGFTG---DQRFFlgwaqvwrskaRDEAL----------RQRLATDPHSPGEFRVNGP 644
                        410       420
                 ....*....|....*....|....*...
gi 351058118 684 YSNMPQFAKAFNCPIGSPM--NPEKKCK 709
Cdd:COG3590  645 VRNLDAFYEAFDVKPGDKMylAPEDRVR 672
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
99-454 4.56e-23

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 101.99  E-value: 4.56e-23
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118   99 PCQDFYQHFCGKFYEHSAIGQGRmaTKRSTLSKL-------IREFLLKNKTSTSKSENT--MKQVYAKCRELQKIsdlNS 169
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHPIPADK--SSWGTFDELrernekqLREILEEAAASESDPGAVekAKDLYKSCMDTDAI---EK 75
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118  170 IPPQALLDIfsdIKKIGAWPVLDkdwdgSKFNLNEMLRQLVNLGetHLGFFHFD-------------FIARP-------- 228
Cdd:pfam05649  76 LGLKPLKPL---LDEIGGPLANK-----DKFDLLETLAKLRRYG--VDSLFGFGvgpddknssrnilYLDQPglglpdrd 145
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118  229 -YVLIKPPLKQGVQKSVLEKVVKM-----ILEANEIKMDQGF------------SEDLDEYFELSNRIKIDKLPRtsrsi 290
Cdd:pfam05649 146 yYLKDRDEKSAEIREAYKAYIAKLltllgASEEAAALAEEVLafetklakaslsREERRDPEKTYNPMTLAELQK----- 220
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118  291 vgLLPDvrrINFRGLILEMMprskmnrFLGTLFQKVVTYHhPLFVRdnetnHLDTIIRSTSNRALANYLIFNFIHSSIKF 370
Cdd:pfam05649 221 --LAPG---IDWKAYLNAAG-------LPDVPSDEVIVSQ-PEYLK-----ALSKLLAETPLRTLKNYLIWRLVRSLAPY 282
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 351058118  371 LT--------------FGLKS-DR-ERCEKIVVQELPRPSLRVFMRNCVDKGNREEVAKLTETVKENVLEMIRESDSFTP 434
Cdd:pfam05649 283 LSdefrdanfefygtlSGTKQrPRwKRCVSLVNGLLGEALGRLYVKKYFPEEAKARVEELVENIKEAFRERLDELDWMDE 362
                         410       420
                  ....*....|....*....|
gi 351058118  435 SVKKRVLKKVEAIGAIIGYP 454
Cdd:pfam05649 363 ETKKKALEKLDAMTVKIGYP 382
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH